Connect with us

Government

5 Biotech Stocks To Check Out In The Stock Market Now

Could these top biotech stocks be worth investing in for the long term?
The post 5 Biotech Stocks To Check Out In The Stock Market Now appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Published

on

5 Top Biotech Stocks For Your November 2021 Watchlist

While investors digest the latest round of earnings and data concerning retail spending, the biotech industry remains hard at work. Accordingly, biotech stocks could also be in focus in the stock market because of this. Ever since the onslaught of the coronavirus pandemic, the industry as a whole has been put under the microscope. As such, positive updates and notable developments in the research processes of companies could draw more attention from investors now. This continues to ring true, especially for biotech stocks developing treatments for the coronavirus.

For example, GlaxoSmithKline (NYSE: GSK) and Vir Biotechnology (NASDAQ: VIR) are among such names today. Notably, the duo reportedly signed a $1 billion contract with the U.S. government for their coronavirus treatment, sotrovimab. According to GSK CEO Hal Barron, the growing number of breakthrough cases would warrant the need for the company’s treatment. Given its purpose as an early antibody-based treatment for the virus, this would serve to bolster the country’s anti-pandemic efforts.

At the same time, biotechs such as Progenity (NASDAQ: PROG), a genetic testing firm, continue to cater to consumer markets as well. For the most part, there seems to be no shortage of exciting news to consider in the biotech space today. On that note, could one of these biotech stocks be top picks in the stock market today?

Best Biotech Stocks To Watch Right Now

Pfizer Inc.

First up, we have Pfizer, a biopharmaceutical company that has developed many life-changing drugs and therapies for millions all over the world. Notably, its coronavirus vaccine is well on track to have over 2 billion doses delivered by the end of the year. PFE stock currently trades at $51.14 as of 2:44 p.m. ET and is up by over 38% year-to-date. On November 16, 2021, the company announced that it will be seeking emergency use authorization (EUA) for its novel coronavirus oral antiviral candidate.

biotech stocks to buy (PFE stock)

If approved, PAXLOVID will be the first oral antiviral of its kind, a 3CL protease inhibitor specifically designed to combat the virus. The EUA submission includes clinical data from an interim analysis of its Phase 2/3 EPIC-HR study, which demonstrated an impressive 89% reduction in risk of coronavirus-related hospitalization or death when compared to placebo in adults with the virus.

It also has rolling submissions in several countries like the U.K., Australia, New Zealand, and South Korea and also has planned submissions to other regulatory agencies around the world. Today, the company also announced that it has completed the acquisition of Trillium Therapeutics. For these reasons, is PFE stock worth adding to your portfolio right now?

[Read More] Best Lithium Battery Stocks To Buy Now? 4 To Know

Novavax Inc.

Novavax is a biotech company that develops and commercializes innovative vaccines to prevent serious infectious diseases. Through its proprietary recombinant technology platform, it combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. NVAX stock currently trades at $190.89 as of 2:44 p.m. ET and is up by over 68% year-to-date.

best biotech stocks (NVAX stock)

Today, the company announced together with Serum Institute India, that the Philippine Food and Drug Administration has granted EUA for Novavax’s coronavirus vaccine. The vaccine will be manufactured and marketed in the Philippines by Serum Institute under the brand name COVOVAX.

With less than a third of the Philippine population fully immunized, we expect the option for a protein vaccine, built on a well-understood technology platform, to contribute substantially to increased vaccination rates,” said Stanley C. Erck, President, and Chief Executive Officer, Novavax. Following this development, will you be adding NVAX stock to your watchlist?

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals is a biotechnology company that focuses on bringing precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with HPV. In fact, it is the first company to have clinically demonstrated that a DNA vaccine candidate can be delivered directly into cells in the body. It does this through a proprietary smart device to produce a robust and tolerable immune response. INO stock currently trades at $7.19 as of 2:46 p.m. ET.

best coronavirus stocks to buy (INO stock)

On Tuesday, the company announced a collaboration with GuardRX and Geneva University Hospitals for a heterologous booster clinical trial for its Ebola DNA vaccine candidate. The trial will assess whether INO-4201 can be used as a booster in healthy volunteers previously vaccinated with rVSV-ZEBOV, an FDA- and EMA-approved viral-based vector Ebola vaccine.

It follows the company’s pre-clinical and Phase 1 trials which suggested to investigators that INO-4201 was well-tolerated and resulted in 100% seroconversion after two doses. With that in mind, should you consider adding INO stock to your watchlist?

AbbVie Inc.

Following that, we will be taking a look at AbbVie. As a prominent name in the global biopharmaceutical industry, ABBV stock could be a go-to for biotech investors now. For one thing, the company’s developmental pipeline spans a vast array of therapeutic areas. This includes but is not limited to the fields of immunology, oncology, virology, and eye care. As it stands, ABBV stock currently trades at $117.00 a share as of 2:47 p.m. ET.

best dividend stocks (ABBV stock)

Even after gaining by over 8% in the past month, AbbVie does not seem to be slowing down anytime soon. This week, the company revealed its latest regulatory win in the E.U.

Namely, the European Commission approved SKYRIZI, AbbVie’s treatment for adults with Active Psoriatic Arthritis. According to AbbVie, this provides Marketing Authorization for the drug in the E.U., Iceland, and Norway. Considering all this, will ABBV stock make your list of top biotech stocks to buy?

[Read More] 5 Metaverse Stocks To Watch In November 2021

Sanofi SA

Last but not least is Sanofi, a French multinational pharmaceutical firm. By the company’s estimates, it is among the largest players in the global pharmaceuticals industry in terms of prescription sales. From its general vaccine offerings to its innovative treatments for pain-related illnesses, Sanofi brings plenty to the table. For a sense of scale, Sanofi currently boasts a global workforce of over 100,000 people with operations across 100 countries.

best health care stocks to buy now (SNY stock)

Now, while SNY stock trades at $50.30 as of 2:48 p.m. ET, could it be worth investing in? If anything, the company does not appear to be slowing down anytime soon on the operational front.

Last week, Sanofi finalized its acquisition of Kadmon Holdings, a fully integrated biopharma firm. Through the $1.9 billion deal, Sanofi hopes to facilitate the growth and expansion of its General Medicines portfolio. Based on all this information, will SNY stock be on your biotech stock watchlist moving forward?

The post 5 Biotech Stocks To Check Out In The Stock Market Now appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

Survey Shows Declining Concerns Among Americans About COVID-19

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat"…

Published

on

Survey Shows Declining Concerns Among Americans About COVID-19

A new survey reveals that only 20% of Americans view covid-19 as "a major threat" to the health of the US population - a sharp decline from a high of 67% in July 2020.

(SARMDY/Shutterstock)

What's more, the Pew Research Center survey conducted from Feb. 7 to Feb. 11 showed that just 10% of Americans are concerned that they will  catch the disease and require hospitalization.

"This data represents a low ebb of public concern about the virus that reached its height in the summer and fall of 2020, when as many as two-thirds of Americans viewed COVID-19 as a major threat to public health," reads the report, which was published March 7.

According to the survey, half of the participants understand the significance of researchers and healthcare providers in understanding and treating long COVID - however 27% of participants consider this issue less important, while 22% of Americans are unaware of long COVID.

What's more, while Democrats were far more worried than Republicans in the past, that gap has narrowed significantly.

"In the pandemic’s first year, Democrats were routinely about 40 points more likely than Republicans to view the coronavirus as a major threat to the health of the U.S. population. This gap has waned as overall levels of concern have fallen," reads the report.

More via the Epoch Times;

The survey found that three in ten Democrats under 50 have received an updated COVID-19 vaccine, compared with 66 percent of Democrats ages 65 and older.

Moreover, 66 percent of Democrats ages 65 and older have received the updated COVID-19 vaccine, while only 24 percent of Republicans ages 65 and older have done so.

“This 42-point partisan gap is much wider now than at other points since the start of the outbreak. For instance, in August 2021, 93 percent of older Democrats and 78 percent of older Republicans said they had received all the shots needed to be fully vaccinated (a 15-point gap),” it noted.

COVID-19 No Longer an Emergency

The U.S. Centers for Disease Control and Prevention (CDC) recently issued its updated recommendations for the virus, which no longer require people to stay home for five days after testing positive for COVID-19.

The updated guidance recommends that people who contracted a respiratory virus stay home, and they can resume normal activities when their symptoms improve overall and their fever subsides for 24 hours without medication.

“We still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses, this includes vaccination, treatment, and staying home when we get sick,” CDC director Dr. Mandy Cohen said in a statement.

The CDC said that while the virus remains a threat, it is now less likely to cause severe illness because of widespread immunity and improved tools to prevent and treat the disease.

Importantly, states and countries that have already adjusted recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19,” it stated.

The federal government suspended its free at-home COVID-19 test program on March 8, according to a website set up by the government, following a decrease in COVID-19-related hospitalizations.

According to the CDC, hospitalization rates for COVID-19 and influenza diseases remain “elevated” but are decreasing in some parts of the United States.

Tyler Durden Sun, 03/10/2024 - 22:45

Read More

Continue Reading

Government

Rand Paul Teases Senate GOP Leader Run – Musk Says “I Would Support”

Rand Paul Teases Senate GOP Leader Run – Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump…

Published

on

Rand Paul Teases Senate GOP Leader Run - Musk Says "I Would Support"

Republican Kentucky Senator Rand Paul on Friday hinted that he may jump into the race to become the next Senate GOP leader, and Elon Musk was quick to support the idea. Republicans must find a successor for periodically malfunctioning Mitch McConnell, who recently announced he'll step down in November, though intending to keep his Senate seat until his term ends in January 2027, when he'd be within weeks of turning 86. 

So far, the announced field consists of two quintessential establishment types: John Cornyn of Texas and John Thune of South Dakota. While John Barrasso's name had been thrown around as one of "The Three Johns" considered top contenders, the Wyoming senator on Tuesday said he'll instead seek the number two slot as party whip. 

Paul used X to tease his potential bid for the position which -- if the GOP takes back the upper chamber in November -- could graduate from Minority Leader to Majority Leader. He started by telling his 5.1 million followers he'd had lots of people asking him about his interest in running...

...then followed up with a poll in which he predictably annihilated Cornyn and Thune, taking a 96% share as of Friday night, with the other two below 2% each. 

Elon Musk was quick to back the idea of Paul as GOP leader, while daring Cornyn and Thune to follow Paul's lead by throwing their names out for consideration by the Twitter-verse X-verse. 

Paul has been a stalwart opponent of security-state mass surveillance, foreign interventionism -- to include shoveling billions of dollars into the proxy war in Ukraine -- and out-of-control spending in general. He demonstrated the latter passion on the Senate floor this week as he ridiculed the latest kick-the-can spending package:   

In February, Paul used Senate rules to force his colleagues into a grueling Super Bowl weekend of votes, as he worked to derail a $95 billion foreign aid bill. "I think we should stay here as long as it takes,” said Paul. “If it takes a week or a month, I’ll force them to stay here to discuss why they think the border of Ukraine is more important than the US border.”

Don't expect a Majority Leader Paul to ditch the filibuster -- he's been a hardy user of the legislative delay tactic. In 2013, he spoke for 13 hours to fight the nomination of John Brennan as CIA director. In 2015, he orated for 10-and-a-half-hours to oppose extension of the Patriot Act

Rand Paul amid his 10 1/2 hour filibuster in 2015

Among the general public, Paul is probably best known as Capitol Hill's chief tormentor of Dr. Anthony Fauci, who was director of the National Institute of Allergy and Infectious Disease during the Covid-19 pandemic. Paul says the evidence indicates the virus emerged from China's Wuhan Institute of Virology. He's accused Fauci and other members of the US government public health apparatus of evading questions about their funding of the Chinese lab's "gain of function" research, which takes natural viruses and morphs them into something more dangerous. Paul has pointedly said that Fauci committed perjury in congressional hearings and that he belongs in jail "without question."   

Musk is neither the only nor the first noteworthy figure to back Paul for party leader. Just hours after McConnell announced his upcoming step-down from leadership, independent 2024 presidential candidate Robert F. Kennedy, Jr voiced his support: 

In a testament to the extent to which the establishment recoils at the libertarian-minded Paul, mainstream media outlets -- which have been quick to report on other developments in the majority leader race -- pretended not to notice that Paul had signaled his interest in the job. More than 24 hours after Paul's test-the-waters tweet-fest began, not a single major outlet had brought it to the attention of their audience. 

That may be his strongest endorsement yet. 

Tyler Durden Sun, 03/10/2024 - 20:25

Read More

Continue Reading

Government

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While “Waiting” For Deporation, Asylum

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several…

Published

on

The Great Replacement Loophole: Illegal Immigrants Score 5-Year Work Benefit While "Waiting" For Deporation, Asylum

Over the past several months we've pointed out that there has  been zero job creation for native-born workers since the summer of 2018...

... and that since Joe Biden was sworn into office, most of the post-pandemic job gains the administration continuously brags about have gone foreign-born (read immigrants, mostly illegal ones) workers.

And while the left might find this data almost as verboten as FBI crime statistics - as it directly supports the so-called "great replacement theory" we're not supposed to discuss - it also coincides with record numbers of illegal crossings into the United States under Biden.

In short, the Biden administration opened the floodgates, 10 million illegal immigrants poured into the country, and most of the post-pandemic "jobs recovery" went to foreign-born workers, of which illegal immigrants represent the largest chunk.

Asylum seekers from Venezuela await work permits on June 28, 2023 (via the Chicago Tribune)

'But Tyler, illegal immigrants can't possibly work in the United States whilst awaiting their asylum hearings,' one might hear from the peanut gallery. On the contrary: ever since Biden reversed a key aspect of Trump's labor policies, all illegal immigrants - even those awaiting deportation proceedings - have been given carte blanche to work while awaiting said proceedings for up to five years...

... something which even Elon Musk was shocked to learn.

Which leads us to another question: recall that the primary concern for the Biden admin for much of 2022 and 2023 was soaring prices, i.e., relentless inflation in general, and rising wages in particular, which in turn prompted even Goldman to admit two years ago that the diabolical wage-price spiral had been unleashed in the US (diabolical, because nothing absent a major economic shock, read recession or depression, can short-circuit it once it is in place).

Well, there is one other thing that can break the wage-price spiral loop: a flood of ultra-cheap illegal immigrant workers. But don't take our word for it: here is Fed Chair Jerome Powell himself during his February 60 Minutes interview:

PELLEY: Why was immigration important?

POWELL: Because, you know, immigrants come in, and they tend to work at a rate that is at or above that for non-immigrants. Immigrants who come to the country tend to be in the workforce at a slightly higher level than native Americans do. But that's largely because of the age difference. They tend to skew younger.

PELLEY: Why is immigration so important to the economy?

POWELL: Well, first of all, immigration policy is not the Fed's job. The immigration policy of the United States is really important and really much under discussion right now, and that's none of our business. We don't set immigration policy. We don't comment on it.

I will say, over time, though, the U.S. economy has benefited from immigration. And, frankly, just in the last, year a big part of the story of the labor market coming back into better balance is immigration returning to levels that were more typical of the pre-pandemic era.

PELLEY: The country needed the workers.

POWELL: It did. And so, that's what's been happening.

Translation: Immigrants work hard, and Americans are lazy. But much more importantly, since illegal immigrants will work for any pay, and since Biden's Department of Homeland Security, via its Citizenship and Immigration Services Agency, has made it so illegal immigrants can work in the US perfectly legally for up to 5 years (if not more), one can argue that the flood of illegals through the southern border has been the primary reason why inflation - or rather mostly wage inflation, that all too critical component of the wage-price spiral  - has moderated in in the past year, when the US labor market suddenly found itself flooded with millions of perfectly eligible workers, who just also happen to be illegal immigrants and thus have zero wage bargaining options.

None of this is to suggest that the relentless flood of immigrants into the US is not also driven by voting and census concerns - something Elon Musk has been pounding the table on in recent weeks, and has gone so far to call it "the biggest corruption of American democracy in the 21st century", but in retrospect, one can also argue that the only modest success the Biden admin has had in the past year - namely bringing inflation down from a torrid 9% annual rate to "only" 3% - has also been due to the millions of illegals he's imported into the country.

We would be remiss if we didn't also note that this so often carries catastrophic short-term consequences for the social fabric of the country (the Laken Riley fiasco being only the latest example), not to mention the far more dire long-term consequences for the future of the US - chief among them the trillions of dollars in debt the US will need to incur to pay for all those new illegal immigrants Democrat voters and low-paid workers. This is on top of the labor revolution that will kick in once AI leads to mass layoffs among high-paying, white-collar jobs, after which all those newly laid off native-born workers hoping to trade down to lower paying (if available) jobs will discover that hardened criminals from Honduras or Guatemala have already taken them, all thanks to Joe Biden.

Tyler Durden Sun, 03/10/2024 - 19:15

Read More

Continue Reading

Trending